Vertex Pharmaceuticals
Biotech · Public
Small molecule CFTR modulators (Trikafta and related compounds) for treating cystic fibrosis
vrtx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 17 granted · 23 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2869 | NUTRIWYO, LLC | — | — |
| 2870 | Nutcracker Therapeutics | — | $172M |
| 2871 | REDVAULT BIOSCIENCES LP | — | — |
| 2872 | Vertex Pharmaceuticals | — | — |
| 2873 | Q-State Biosciences, Inc. | — | — |
| 2874 | NEUCORE BIO, INC. | — | — |
| 2875 | PROMILEAD, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
Sionna’s cystic fibrosis flop sends stock down 90%, but a ‘significant positive’ for VertexFierceBiotech
Patents
- Methods Of Enhancing Stem Cell Differentiation Into Beta Cellsapplication
- Methods Of Enhancing Stem Cell Differentiation Into Beta Cellsapplication
- Cell Therapy For Diabetes In Transplant Recipientsapplication
- Processes For Preparing Modulators Of ALPHA-1 Antitrypsingranted
- Substituted Macrocyclic Amine Modulators Of Orexin Receptor 2application
- Hydroxy And (halo)alkoxy Substituted Tetrahydrofurans As Modulators Of Sodium Channelsgranted
- 7- Or 8-HYDROXY-ISOQUINOLINE And 7- Or 8-HYDROXY-QUINOLINE Derivatives As ALPHA-1-ANTITRYPSIN Modulators For Treating ALPHA-1-ANTITRYPSIN Deficiency (aatd)granted
- Multicompartment Macroencapsulation Devicesapplication
- Compositions And Methods For Editing Beta-globin For Treatment Of Hemaglobinopathiesgranted
- Implantation And Transport Systems For Use With Macroencapsulation Devices And Related Methodsapplication
- Materials And Methods For Treatment Of Hemoglobinopathiesgranted
- Methods Of Enhancing Stem Cell Differentiation Into Beta Cellsgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.